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Aspects specific to infants 
and small children
In children younger than 7 years of age, CMR usually 
needs to be performed under sedation or general an-
aesthesia. However, in neonates and infants under 
6 months of age, a successful examination can also be 
performed without sedation or general anaesthesia, by 
using the “feed and wrap” technique [5]. CMR in infants 
Abbreviations: 
AV = atrioventricular
BCPC = bidirectional cavopulmonary connection
CE MRA = contrast-enhanced magnetic resonance 
  angiography
CHD = congenital heart disease
CMR = cardiac magnetic resonance
GBCA = gadolinium-based contrast agent
ICD = implantable cardioverter-defibrillator
IVC = inferior vena cava
LGE = late gadolinium enhancement
LPA = left pulmonary artery
MPA = main pulmonary artery
LV = left ventricle
OT = outflow tract
PDA = patent ductus arteriosus
PR = pulmonary regurgitation
PC CMR = phase contrast cardiac magnetic resonance
PA = pulmonary artery
PR = pulmonary regurgitation
Qp/Qs = ratio of pulmonary to systemic blood flow
RPA = right pulmonary artery
RV = right ventricle
SVC = superior vena cava
SSFP = steady-state free precession
TCPC  = total cavopulmonary connection
TGA = transposition of the great arteries
VSD  = ventricular septal defect
Introduction
This document has been written by paediatric and 
adult cardiologists as well as radiologists with exper-
tise in the field of congenital heart disease (CHD) imag-
ing from the five university hospitals in Switzerland. 
Cardiac magnetic resonance (CMR) is one of the basic 
imaging modalities for assessment of CHD, with 
 increasing use. This document aims to harmonise 
 imaging protocols and seeks high quality and compa-
rability of CMR examinations between centres treat-
ing paediatric and adult CHD patients in Switzerland. 
Comparable image quality will simplify scientific col-
laboration and facilitate designing prospective studies. 
The document summarises in a first part (sections 2 to 
5) general and technical aspects of CMR in CHD. The 
second part (section 6) provides protocols for the most 
common congenital heart defects, based on current 
guidelines and position papers [1–4]. We define for 
every lesion the standard for a comprehensive CMR 
 examination by describing the mandatory and 
 optional sequences that should be acquired. However, 
every centre is free to expand the protocols according 
to patients’ individual clinical situations and indica-
tions, as well as to address centre-specific issues. This 
document does not replace standard CMR textbooks or 
international guidelines published by, for example, the 
Society of Cardiac Magnetic Resonance or the Euro-
pean Society of Cardiology [1–3].
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and small children poses technical challenges because 
of the small size of the structures and rapid heart rates, 
which require sequence optimisation [6]. High spatial 
resolution can be achieved by using thin slices, a small 
field of view and a large matrix. To maintain a high sig-
nal to noise ratio, smaller multi-element coils and 
multi ple signal averages are often necessary. Achiev-
ing a high temporal resolution requires decreasing the 
number of views per segment. For contrast-enhanced 
magnetic resonance angiography (CE MRA) in infants, 
the small volumes of contrast used are best injected by 
hand (injection during 80% of scan time).
Safety aspects
General
Common contraindications for CMR must be respected 
(claustrophobia, non-CMR compatible neuro-
stimulators, insulin pumps, epidural pumps, etc.). 
Gadolinium-based contrast agents
Gadolinium-based contrast agents (GBCAs) are gener-
ally safe; however, a few restrictions and contraindica-
tions exist and must be respected [7]. Major adverse 
events are very rare, and consist of allergic reactions 
and nephrogenic systemic fibrosis [7]. Nephrogenic 
systemic fibrosis is an exceedingly rarely reported gen-
eralised disease. Risk is increased in patients with 
 severely decreased renal function and a glomerular fil-
tration rate below 30 ml/min. More recently, deposi-
tion of gadolinium in the brain has been  reported in 
patients who underwent repeated magnetic resonance 
imaging (more than five times) for various (non-
cardiac) indications; the clinical significance of this 
finding is not known yet. In general, if administration 
of GBCAs is required, such as for angiography, perfu-
sion studies or late gadolinium enhancement, the use 
of nonlinear, cyclic GBCAs is preferred, as for this 
group of contrast agents no or very few cases of 
nephrogenic systemic fibrosis have been reported and 
brain deposition may be less [8–11]. In patients with a 
glomerular filtration rate below 30 ml/min, the use of 
a cyclic GBCA should be carefully weighed against the 
potential risks and, if possible, avoided, while some lin-
ear GBCAs are contraindicated [12]. If the use of GBCAs 
is definitely contraindicated, then 3D steady-state free 
precession (SSFP) sequences are a valuable alternative, 
obviating the need for CE MRA.
Administration of GBCAs to children below 2 years of 
age is currently off-label use and only cyclic GBCAs 
should be used. 
Pacemakers, implantable cardioverter- 
defibrillators, epicardial pacemaker leads
CMR is generally contraindicated in patients after 
pacemaker or implantable cardioverter-defibrillator 
(ICD) implantation. However, several implantable elec-
trodes and generators of the newer generations are 
CMR conditional; performing CMR examinations with 
these  devices is safe and yields high-quality images 
[13]. Precautions and limitations of the implanted 
 devices and electrodes must be respected [14, 15]. The 
presence of epicardial pacemaker leads is still a 
 contraindication for CMR because of potential heating 
of the leads. In patients who have undergone cardiac 
 surgery, a chest X-ray is recommended after surgery 
and/or before the CMR examination to exclude the 
presence of residual epicardial pacemaker leads.
Pregnancy, breast-feeding
The risks and benefits of any imaging modality in preg-
nant patients must be balanced. CMR with maximum 
field strength of 1.5 T is considered safe regardless of 
gestational age when the benefit outweighs the risks; 
however, if possible it should be postponed until after 
the first trimester [16]. CMR should be preferred to 
radio active imaging modalities [17]. The use of GBCAs 
in pregnancy should be avoided as they cross the 
blood-placenta barrier and their effects on the fetus 
are not known [16, 18]. Only in clinical situations that 
do not allow the required information to be obtained 
without contrast agents, the use of GBCAs can be dis-
cussed, and the lowest possible dose should be admin-
istered. 
A very small percentage of the GBCA dose, which is 
much lower than the maximum permitted intra-
venous dose for infants, is excreted in breast milk 
 after intravenous administration to breast-feeding 
 patients [19]. Nevertheless, interruption of  breast- 
feeding for 24 hours after exposure to a GBCA is recom-
mended.
Myocardial stress perfusion examinations 
A medical doctor with training in cardiopulmonary 
 resuscitation must be present during myocardial 
 perfusion studies with adenosine, dipyridamole or 
dobutamine. Medication for cardiopulmonary life sup-
port and an external cardioverter-defibrillator must be 
available outside the scanning room and be ready for 
use. 
Medical devices and implants 
other than pacemakers and ICDs
Respect the recommendations for use of the different 
implantable medical devices when performing CMR. 
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 Information about product safety is available on dedi-
cated websites (e.g., www.mrisafety.com).
Technical aspects
The imaging parameters given in the tables represent 
the consensus among the different centres and are in 
agreement with current recommendations [1–3].
Field strength
Current recommended field strengths are 1.5 or 3 T. 
Sequences
Visualisation of anatomy 
Sequences: SSFP, spin echo, fast spin echo.
Cine imaging
Sequences: SSFP, standard spoiled gradient echo pulse 
sequence (technical details see table 1).
Contrast-enhanced magnetic resonance angiog-
raphy
A GBCA dose of 0.1–0.2 mmol/kg is injected as a bolus. 
In children, administration during 80% of the image 
acquisition time is proposed. Image acquisition 
should, if possible, be during breath holding; timing of 
 acquisition depends on the vascular structure to be 
visualised. Depending on indication, consider time- 
resolved CE MRA (for example see fig. 1), for technical 
details see table 2.
3D whole heart (SSFP)
Whole heart imaging is performed using 3D SSFP, 
 eithe r ECG triggered and respiratory navigator gated 
during free breathing, or self-navigation 3D  approaches 
with isotropic resolution (for resolution see table 3) 
[20–22]. Acquisition volume is adapted to patient col-
laboration and targeted structures to be visualised in 
order to minimise scan time and optimise quality. 
Ventricular volumetry 
Acquisition: We recommend acquiring a short-axis 
stack of contiguous slices covering both ventricles 
from base to apex, with the first and last slices without 
ventricular mass to ensure a complete coverage of the 
ventricles (figs 2a and 2b). For dilated and hyper-
trophied right ventricles, a separate stack oriented 
 parallel to the tricuspid valve plane to assure optimal 
alignment should be considered. Additionally, a 
transaxial stack or long-axis stack can be considered in 
specific lesions. Details of cine imaging according to 
patient size are  described in table 1. 
Table 1: Technical details of steady-state free precession.
10 kg 10 kg
In-plane resolution (mm) 1.0–1.5 1.3–2.0
Slice thickness (mm) 3–7 6–8 
Temporal resolution 25–50 ms (or 4–5% of RR interval) 35–50 ms
Number of signal averages 1–3 (higher signal averages if free 
 breathing in small children)
1–2
Respiratory compensation Free breathing Breath-hold Breath-hold
Interslice gap (mm) 0–2 0–2 
Reconstructed phases 25–40 25–40
ECG gating Retrospective or prospective if arrhythmia
Table 2: Technical details of contrast-enhanced magentic resonance angiography.
10 kg 10 kg
In-plane resolution (mm)* ≤1.2 × ≤1.2 ≤1.5 × ≤1.5
Slice thickness (mm) ≤1.2 ≤2
Respiratory compensation Free breathing Breath-hold Breath-hold
* Resolution can be lowered if whole thorax is covered or if difficulties with breath holding. 
Table 3: Technical details 3D whole heart imaging, with or without navigator technique.
10 kg 10 kg
Isotropic resolution (mm3) 1.2–1.5 1.3–2.0
Navigator window (mm) 3 5
Image acquisition window (ms) 40–60 80–150
Trigger delay Endsystole or mid-diastole Mid-diastole
Figure 1: Contrast-enhanced CMR angiography. 
Severe coarctation with large collaterals. The descending 
aorta is almost interrupted (A and B). Hypoplastic aortic arch 
and large pseudoaneurysm 28 years after patch repair for 
aortic coarctation (C). 
Patient from figure 1 with situs inversus and univentricular 
heart and TCPC. A persistant right superior vena cava (SVC) 
is still connected to the atrium and accounts for a R−L shunt 
(D).
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Analysis: The use of dedicated software is recom-
mended. Endo- and epicardial left and right ventricular 
borders are manually traced at end-diastole and 
end-systole. The papillary muscles are included in the 
blood pool. The interventricular septum is included in 
the left ventricular (LV) mass. Practice varies regarding 
whether the right ventricular (RV) trabeculations are 
excluded from or included in the blood pool. However, 
higher reproducibility has been reported for segmen-
tation along the compacted myocardium and inclusion 
of trabeculations in the blood pool [23]. In the case of 
bundle-branch block, the end-diastolic and end -
systolic phases of the right and left ventricles may 
 occur at different times; thus the phase with the 
 largest/smallest ventricular volume has to be evalu-
ated for each ventricle independently. The RV outflow 
tract (OT) should be considered part of the right ventri-
cle, even in cases with aneurysmatic dilatation such as 
in patients with repaired tetralogy of Fallot. Contour 
data for volumetric analysis should be stored in a data-
base and remain available for comparison at the time 
of a subsequent examination [1, 2]. 
Flow measurements by phase contrast CMR 
Acquisition: Phase contrast (PC) CMR images are usu-
ally acquired strictly perpendicular to the course of 
the vessel and tailored with use two orthogonal plan-
ning views (double oblique). The region of interest 
Figure 2a: SSFP short axis cine stack with volumetry of both ventricles. Top: Tracings of the RV and LV endocardial borders and 
LV epicardial border. Bottom: SSFP end-diastolic still frame of 4-chamber view. Systolic tracings of the RV and LV endocardial 
borders. LV ejection fraction (EF) 61%, LV end-diastolic volume index (EDVi) 94 ml/m2, LV endsystolic volume index (ESVi) 37 ml/
m2, LV mass index 67 g/m2. RVEF 61%, RVEDVi 80 ml/m2, RVESVi 31 ml/m2. Patient with surgically repaired patent ductus arte-
riosus and correction of coronary anomaly (left anterior descending artery originating from MPA), mild aortic regurgitation.
Figure 2b: Univentricular heart with situs inversus, mesocardia, unbalanced atrioventricular (AV) septal defect with common AV 
valve, right ventricular dominance, transposition and total cavopulmonary connection (TCPC). 
Top: SSFP long axis cine still frames and abdominal situs. 
Bottom: SSFP short axis cine stack with volumetry of both ventricles together: VEDVi 125 ml/m2, EF 42%.
Table 4: Technical details of phase contrast CMR.
10 kg 10 kg
In-plane resolution (mm) 1.0–1.2 1.0–2.0
Slice thickness (mm) 4–5 4–6
Temporal resolution 25–50 ms or 5%  
of RR interval
25–50 ms or 5%  
of RR interval
Number of signal averages 1–3
Reconstructed phases per RR interval 20–30
Velocity encoding (cm/s) To be set according to expected maximum  
velocities (under normal conditions: artery 
150 cm/s, vein 80–100 cm/s, AV valve inflow  
150 cm/s)
Cardiac/respiratory motion Retrospective ECG gating, with or without 
breath-hold (see text)
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should be positioned in the isocentre of the scanner 
(figs 3a and 3b) [24]. 
Velocity encoding of approximately 120% of expected 
maximum velocity is used to optimise the dynamic 
range and assure absence of aliasing. Breath-hold 
 acquisitions are associated with fewer motion arti-
facts. Non-breath-hold acquisitions are suggested in 
the Fontan circulation and for venous flow measure-
ments, or when higher temporal and spatial resolution 
are required [25]. In the case of turbulent flow in the 
main pulmonary artery (MPA), flow measurements in 
the right and left branch pulmonary arteries or in each 
pulmonary vein to calculate pulmonary stroke volume 
are recommended. In the case of turbulent flow in the 
ascending aorta, try to perform PC CMR just before 
aortic arch branching (for technical details see table 4). 
Analysis: Contours should be traced in all phases on 
the magnitude images using dedicated software. The 
presence of offset errors has been reported for scan-
ners of all vendors, and may reduce the accuracy of the 
results [24]. Thus correction for offset errors is strongly 
recommended; this can be achieved by repeating 
measurements on a gel phantom or by measuring the 
signal of an area of similar size to the vessel of interest 
in nearby stationary tissue. Some newer post-process-
ing software versions also offer an integrated flow cor-
rection algorithm. 
Myocardial stress perfusion 
Perfusion studies should be performed according to 
standard protocols with pulse sequences achieving the 
parameters given in table 5 [1, 2, 26, 27]. 
Contraindications must be carefully ruled out.  Patients 
are prepared with absence of caffeine intake, etc. be-
fore the examination, as proposed by standard proto-
cols (see also section 3 ‘Safety aspects’).
Sequences: gradient echo, gradient echo-planar, SSFP. 
Typical parameters for a T1-weighted saturation-recov-
ery gradient echo sequence for first-pass myocardial 
perfusion imaging are given in table 5. 
Vasoactive agents: adenosine (140 µ/kg/min), dipyrida-
mole. 
After at least 3 minutes of vasodilator perfusion, a 
 bolu s of a GBCA (0.05–0.1 mmol/kg) at 5 ml/s is injected 
followed by a flush of saline (25 ml at 5 ml/s) (children 
10 ml with 3 ml/s).
Minimum three (adults three–five) short-axis slices 
are used to cover the left ventricle.
Scanning of 60 heartbeats after start of contrast agent 
infusion guarantees full coverage of the GBCA first 
pass during the breath-hold manoeuvre.
Figure 3a: A patient with transannular patch repair and ventricular septal defect (VSD) 
closure for tetralogy of  Fallot and residual pulmonary regurgitation (PR). Still frame of  
a SSFP RVOT cine (A), inplane PC CMR RVOT with diastolic regurgitant jet in black (B), 
throughplane PC in the MPA (C), analysis showing severe PR, regurgitant volume 52 ml, 
regurgitant fraction 40% (D).
Figure 3b: Native coarctation. Throughplane PC CMR. SSFP still frame showing levels of 
PC CMR measurements (A). Flow curve of measurement at the level of coarctation 
 (C− D). Peak velocity across the descending aorta 2.43 m/s (beware of underestimation 
by CMR) (C), flow curve of measurement of descending aorta at the level of diaphragm 
with visualisation of the diastolic run-off (D).
Table 5: Technical details myocardial stress perfusion.
10 kg 10 kg
In-plane resolution (mm) 1.5–2.0 1.5–2.5
Slice thickness (mm) 5–8 8–10
Acquisition of short-axis stack Every 1 RR or 2 RR Every 1 RR or 2 RR
Acquisition window <150 ms <150 ms
Signal increase (% of baseline signal) >250–300% >250–300%
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Late gadolinium enhancement
Late gadolinium enhancement (LGE) imaging should 
be performed according to standardised protocols [1, 
27]:
Available sequences include 2D segmented inversion 
recovery gradient echo pulse and phase-sensitive in-
version recovery (PSIR) sequences. Parameters are 
shown in table 6.
Image acquisition is started 10–20 minutes following 
injection of 0.1–0.2 mmol/kg of GBCA, in breath-hold 
if possible. Usually short-axis, two-, three- and four- 
chamber images are acquired, if necessary RV long-
axis, inflow and outflow view, RVOT view.
Inversion time should be adjusted according to the 
contrast medium dose administered and time after 
 injection.
In infants / small children, spatial resolution can be in-
creased by reducing the size of the voxels and increas-
ing signal averages for more signal. For adequate recov-
ery between inversion pulses, acquisition of every 
third of four heart beats (instead of every other heart 
beat) should be considered. Image acquisition should 
be kept short by using a turbo factor to avoid blurring. 
Reporting: left ventricle 17 segment model, right 
 ventricle 9 segment model [28, 29] (for examples see 
figs 4a and 4b).
Reporting
Bearing in mind that every centre uses its own report 
form, we recommend that a comprehensive report 
should include the aspects listed below.
General
In CHD, description of the segmental anatomy is use-
ful. This includes cardiac situs, cardiac position, rela-
tionship of great arteries, pulmonary and systemic 
 venous return, atrioventricular and ventriculoarterial 
relationships. Quantitative reference values can be 
found in Kawel-Boehm et al. [30].
Ventricular volumetry
End-diastolic and end-systolic ventricular volumes 
(absolu t e and indexed to body surface area), ejection 
fraction and, optionally, mass (absolute and indexed to 
body surface area).
Flow by PC CMR 
Net forward flow, regurgitant fraction and volume if 
applicable; heart rate. 
In the case of turbulent flow in the MPA, use of flow 
measurements in right and left pulmonary branch 
 arteries or in each pulmonary vein to calculate pulmo-
nary stroke volume is recommended. In the case of 
turbulent flow in the ascending aorta, PC CMR can be 
performed just before aortic arc branching.
In the case of significant valvular stenosis, maximum 
flow velocity can theoretically be used to calculate 
pressure gradients with the Bernoulli equation. How-
ever, echocardiography is clearly superior for quantifi-
cation of stenosis and should be preferred to CMR.
Table 6: Technical details late gadolinium enhancement.
10 kg 10 kg
In-plane resolution (mm) 1.0–1.4 1.3–1.7
Slice thickness (mm) 6–8 6–8
Image acquisition timing 3 RR or 4 RR 2 RR
Trigger delay Diastole or systole Diastole
Figure 4a: Late gadolinium enhancement (LGE). 
21-year-old patient with arterial switch for transposition 
of the great arteries (TGA) after postoperative myocardial 
 ischaemia. Extensive area with subendocardial LGE in 
 anterolateral segment (A) and in the inferior mid-ventricular 
segment (B).
Figure 4b: Patient with transannular patch repair and VSD 
closure for tetralogy of Fallot and residual severe PR.
LGE in RVOT aneurysm (A), LGE of the RVOT aneurysm and 
VSD patch area and inferior insertion point (RV hypertrophy) 
(B), LGE in the RV free wall (C−D).
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Vascular dimensions
Exact description of how and where measurements 
have been taken is important for reproducibility and 
comparability of the measurements in the follow-up 
studies. The quality of images, i.e., non-ECG-triggered 
CE MRA or ECG-triggered SSFP, must be specified. The 
aortic root should be visualised and measured with a 
gated sequence, such as SSFP, in order to avoid blurring 
due to the important vessel pulsatility.
Z-score calculators (validated for echocardiography): 
http://marfan.org/; http://www.parameterz.com/.
The following levels of measurement are recom-
mended.
Aorta:
– Root: cusp to cusp, commissure to sinus, measured 
on SSFP or gradient echo, in systole in children, in 
diastole in adults [31]. 
– Sinotubular junction, ascending aorta at right pul-
monary artery level, aortic arch, descending aorta 
at left pulmonary artery level, and at the level of the 
diaphragm, measured on CE MRA.
Pulmonary arteries: 
– MPA, left pulmonary artery (LPA), right pulmonary 
artery (RPA) measured on CE MRA or 3D SSFP.
Protocols for specific lesions
At the end of every examination obtain noninvasively 
blood pressure in the right arm. 
6. 1 Coarctation of the aorta, 
before and after repair
Mandatory Ventricular volumetry
CE MRA or 3D SSFP of thoracic aorta
PC CMR: 
Ascending aorta, descending aorta at the 
level of  diaphragm
LGE (at least once at age of 16 to 20 
 years)
Optional Spin echo aortic arch long axis
Cine CMR aortic root perpendicular to 
vascular axis and aortic arch long axis
PC CMR proximal and distal to coarcta-
tion and descending aorta for assess-
ment of collateral flow
LGE
Key reporting: location, dimensions, and severity of 
aortic obstruction; arch sidedness and branching 
 order; arch dimensions, presence of aneurysm, dissec-
tion or collateral vessels, collateral flow to the descend-
ing aorta; LV volumes and systolic function, ventricu-
lar mass; aortic valve morphology, stenosis, and 
regurgitation (for examples see figs 2b and 3).
Aortic diseases (Marfan, Loeys-Dietz,  familial 
aortic diseases)
Mandatory Ventricular volumetry (RV and LV)
Cine CMR: stack of orthogonal views of 
aortic root, no gap, 4–8 mm slice thickness
CE MRA or 3D SSFP of thoracic and 
 ab dom inal aorta, pulmonary arteries
PC CMR: ascending aorta 
Optional Loeys-Dietz / Ehlers-Danlos syndrome and 
if applicable: CE MRA from head to iliac 
bifurcation
Key reporting elements: description of aortic valve 
morphology, regurgitation, LV and RV volumes and 
systolic function, diameters of thoracic and abdominal 
aorta, ostial coronary arteries (especially after com-
posite graft), signs of dissection, z-score calculators: 
http://marfan.org/; http://www.parameterz.com/ 
D-transposition of great arteries
D-transposition of the great arteries following 
an arterial switch operation
Mandatory Ventricular volumetry (RV and LV)
Cine CMR: long-axis RVOT, LVOT, long-axis 
RV and LV
CE MRA or 3D SSFP of thoracic aorta, 
 pulmonary arteries
PC CMR: ascending aorta, MPA, LPA, RPA
Optional Stress myocardial perfusion and LGE
Cine CMR: long-axis MPA, LPA, RPA
3D SSFP ostial and proximal coronary 
 arteries, PAs, thoracic aorta
Key reporting elements: location and severity of as-
cending aorta, MPA and branch PA obstruction; branch 
PA flow distribution; proximal coronary artery course; 
aortic root dilation; aortic and pulmonary regurgita-
tion; RV and LV volumes and systolic function; myo-
cardial perfusion (if performed)
D-transposition of the great arteries following 
an atrial switch operation
Optional Ventricular volumetry (RV and LV)
Cine CMR: long-axis RVOT, LVOT, long-axis 
SVC and IVC baffle
CE MRA or 3D SSFP of systemic and 
 pulmonary venous return, thoracic aorta, 
pulmonary trunk and arteries
PC CMR: ascending aorta, MPA
Optional PC CMR: systemic/pulmonary venous 
 return, azygos vein
PC CMR: through-/inplane IVC and SVC
LGE
Cine CMR: axial stack and short-axis co-
vering both atria (imaging of baffle leak)
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Key reporting elements: location and severity of sys-
temic and pulmonary venous pathway obstruction, 
baffle leak, LV and RV volumes and systolic function, 
severity and mechanism of left or right ventricular 
outflow tract obstruction, tricuspid regurgitation, ra-
tio of pulmonary to systemic blood flow (Qp/Qs).
Congenitally corrected transposition 
of the great arteries 
Mandatory Ventricular volumetry (RV and LV)
Cine CMR: long-axis RVOT, LV and RV
PC CMR: ascending aorta, MPA
Optional Cine CMR axial stack
CE MRA / 3D SSFP of all intrathoracic 
 vessels
Myocardial stress perfusion, LGE
Key reporting elements: location and severity of sub-
pulmonary obstruction, LV and RV volumes and sys-
tolic function, tricuspid regurgitation, Qp/Qs.
Ebstein’s anomaly of the tricuspid valve
Mandatory Ventricular volumetry (RV and LV)
Cine CMR: long-axis RVOT, LV and RV
Cine CMR: 3- and 4-chamber view tricus-
pid valve
Cine CMR axial stack
PC-CMR: ascending aorta, MPA
Optional CE MRA / 3D SSFP pulmonary arteries  
and aorta
Cine CMR long-axis stack RV
Key reporting elements: description of tricuspid valve 
morphology, apical displacement of the septal leaflet 
(in mm), tethering of the anterior leaflet, severity of 
tricuspid regurgitation, pulmonary stenosis, LV and RV 
volumes and systolic function, presence of an atrial 
septal defect, Qp/Qs based on flow measurements.
Tetraology of Fallot, pulmonary atresia with 
ventricular septal defect, truncus arteriosus 
following complete repair, surgical correction 
with RV–PA conduits
Mandatory Ventricular volumetry (RV and LV)
Cine CMR: long-axis RVOT stack in double 
oblique sagittal plane (especially before 
percutaneous pulmonary valve implanta-
tion)
CE MRA / 3D SSFP of thoracic vasculature 
and proximal coronary arteries
PC CMR: ascending aorta, MPA / RV–PA 
conduit
Optional PC CMR: RPA, LPA, AV valves, SVC, 
 descending aorta at diaphragm
LGE
Cine CMR: long-axis RVOT stack in double 
oblique axial plane (before percutaneous 
pulmonary valve implantation)
Key reporting elements: RV and LV volumes and sys-
tolic function (include RV infundibular aneurysms, if 
present, in RV volumes), RVOT and pulmonary arterial 
anatomy, quantification of pulmonary regurgitant vol-
ume and fraction, branch pulmonary artery flow dis-
tribution, Qp/Qs, proximal coronary artery anatomy 
for percutaneous pulmonary valve implantation.
Partial anomalous pulmonary venous connec-
tion / sinus venosus defect
Mandatory Ventricular volumetry (RV and LV)
Cine CMR: axial stack covering all pulmo-
nary venous connections, oblique stack 
covering anomalous veins, sinus venous 
defect
CE MRA / 3D SSFP of pulmonary venous
return
PC CMR: ascending aorta, MPA
Optional PC CMR: RPA, LPA, pulmonary veins, SVC 
above and below anomalous pulmonary 
veins
Cine CMR: oblique coronal stack covering 
anomalous veins / sinus venosus defect
Key reporting elements: RV and LV volumes and sys-
tolic function, connections and drainage of the pulmo-
nary veins, size of the sinus venosus defect, Qp/Qs (for 
examples see figs 5 and 6).
Functionally single ventricle after bidirectional 
cavopulmonary connection (BCPC)
Mandatory Ventricular volumetry (including all vol-
umes contributing to systemic output)
Cine CMR: 
Axial stack covering the entire thorax
Aortic arch in long axis if status after arch 
enlargement / coarctation repair
CE MRA / 3D SSFP of thoracic vasculature
PC CMR: ascending aorta, SVC, RPA, LPA, 
pulmonary veins, descending aorta at 
 diaphragm, decompressing veins
Optional Time resolved CE MRA
LGE
Key reporting elements: ventricular volumes and sys-
tolic function (including all volumes contributing to 
systemic output, exclude interventricular septum if 
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present), BCPC and pulmonary artery obstruction, 
branch pulmonary artery flow distribution, aortic arch 
obstruction, systemic-pulmonary collateral arteries 
and blood flow, Qp/Qs, veno-venous collaterals.
Borderline LV hypoplasia before surgery
Mandatory Ventricular volumetry (no gap, thinnest 
possible slice, consider gradient echo)
Cine CMR: LVOT long axis, aortic arch 
in long axis
CE MRA / 3D SSFP of thoracic vasculature
PC CMR: ascending aorta 
LGE (endocardial fibroelastosis)
Optional PC CMR: SVC, RPA, LPA, PDA, descending 
aorta at diaphragm, AV valves
Key reporting elements: LV volumes and systolic func-
tion, LV inlet and outlet anatomy, aortic arch and PDA 
anatomy, Qp/Qs, endocardial fibroelastosis.
Fontan circulation
Mandatory Ventricular volumetry
CE MRA / 3D SSFP of thoracic vasculature
PC CMR: ascending aorta, MPA if present
PC CMR (free breathing): branch PAs, SVC, 
IVC
Optional Cine CMR: coronal/oblique stack of Fontan 
baffles and anastomoses in long axis
Cine CMR: long-axis LV and RV, LVOT and 
RVOT, aortic arch if after aortic arch en-
largement / coarctation repair
LGE
PC CMR: AV valves, pulmonary veins, 
aorti c arch if after aortic arch enlarge-
ment  / coarctation repair
Fibrosis imaging of liver
Key reporting elements: Size and function of ventricu-
lar volumes contributing to systemic output (exclude 
interventricular septum if applicable), Fontan path-
way, SVC, IVC, branch PAs, pulmonary vein, and aortic 
arch obstruction; Fontan baffle defects; ventricular 
para meters; valve regurgitation; aortopulmonary or 
pulmonary veno-venous collaterals, Qp/Qs. 
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Figure 5: Uncorrected sinus venosus defect from SVC-type with partial anomalous 
 pulmonary venous drainage (PAPVD) of the right upper pulmonary vein. 
SSFP cine still frames in axial, oblique and sagittal orientation (A−C), SVC with PAPVD 
in SSFP cine still frame (D), PC CMR orthogonal en face view of the defect and L−R shunt 
(black area) (E), CE MRA angiography with visualisation of the the PAPVD (F).
* Sinus venosus defect.
Figure 6: Sinus venosus defect from IVC-type. SSFP cine still 
frame in coronal, oblique and sagittal views (A−C), inplane 
PC CMR with black signal of the L−R shunt. 
* Sinus venosus defect.
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